Webinars
Novel Therapy Update: Protein Degraders for Lymphoma and CLL
Webinars are hour-long virtual programs discussing specific lymphoma subtypes, key updates to the treatment landscape for lymphoma and CLL/SLL, and the latest highlights in diagnostics and supportive care. Webinars include a presentation from the featured expert, with the remainder of the time allocated to an extensive question-and-answer session.
Date: Tuesday, October 20, 2026
Time: 2:00 – 3:00 PM ET
This program is hosted virtually on Zoom and can be accessed online and over the phone. Access instructions will be emailed after registration.
Program Overview
- Current Role of Protein Inhibitors in Treating Lymphoma and CLL
- The Need for Protein Degraders
- How Protein Degraders Work
- Current Data and Response Rates in Lymphoma and CLL
- Side Effects of Protein Degraders
- Ongoing Trials and Future Applications
- Question and Answer Session
Information provided during Lymphoma Research Foundation programs is offered solely for informational and educational purposes and does not constitute and should not be relied upon as professional medical advice, diagnosis, or treatment from a licensed or otherwise appropriate healthcare provider, nor does it create a patient provider relationship. Individuals are encouraged to consult their own healthcare professional regarding any medical questions or conditions.
Register below
Don’t see form? Direct link here.
Patient Education Program Disclaimer
You may also register by calling or emailing our Lymphoma Resource Center at 800-500-9976 or [email protected].
This program is for patients, survivors, care partners, and program supporters. If you are a pharmaceutical industry professional who is interested in attending but your company is not listed as a sponsor, please email [email protected] to learn more about sponsorship.
Program Supporters
This program is supported through unrestricted educational grants from:
